Loading…
Bio-Rad Laboratories, Inc. is projected to rise to $399.34 by 2027, a +22% move from its current price of $326.72. BIO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $321.21 | $326.96 | $332.82 | +0.07% |
| Aug 2 | $319.09 | $327.21 | $335.53 | +0.15% |
| Aug 3 | $317.54 | $327.45 | $337.68 | +0.22% |
| Aug 4 | $316.26 | $327.70 | $339.54 | +0.30% |
| Aug 5 | $315.18 | $327.94 | $341.23 | +0.37% |
| Aug 6 | $314.22 | $328.19 | $342.78 | +0.45% |
| Aug 7 | $313.36 | $328.43 | $344.23 | +0.52% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $313.36 | $328.43 | $344.23 | +0.52% |
| Week 2 | $308.93 | $330.16 | $352.84 | +1.05% |
| Week 3 | $305.95 | $331.89 | $360.02 | +1.58% |
| Week 4 | $303.71 | $333.63 | $366.50 | +2.11% |
| Week 5 | $301.93 | $335.38 | $372.53 | +2.65% |
| Week 6 | $300.49 | $337.14 | $378.25 | +3.19% |
| Week 7 | $299.29 | $338.91 | $383.76 | +3.73% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.
The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories.
The Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc.
was founded in 1952 and is headquartered in Hercules, California.
Bio-Rad Laboratories, Inc. (BIO) is a healthcare company that operates in life science research and clinical diagnostics. It trades with a current price of $314.46 and a market cap of $8.42B, ranking 981.
A major floor 26.0% below — a decisive break under it would weaken the trend.
The nearest floor, 17.3% below — buyers have tended to step in here.
Price is pressing into resistance (1.3% away) — a breakout level to watch.
A major ceiling 13.3% above — clearing it would confirm fresh momentum.
Key BIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $323.17 | Buy | $323.08 | Buy |
| MA 10 | $314.61 | Buy | $316.66 | Buy |
| MA 20 | $305.03 | Buy | $308.77 | Buy |
| MA 50 | $298.32 | Buy | $298.28 | Buy |
| MA 100 | $285.47 | Buy | $292.75 | Buy |
| MA 200 | $295.58 | Buy | $290.48 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.13 | Neutral |
| Stoch RSI (14) | 76.77 | Neutral |
| CCI (20) | 140.42 | Buy |
| Williams %R (14) | -12.13 | Info |
| MACD (12,26,9) | 2.70 | Buy |
| ROC (12) | 9.51 | Buy |
| Bollinger %B (20,2) | 0.93 | Neutral |
| Stochastic %K (14) | 87.87 | Sell |
| TRIX (15) | 0.29 | Buy |
| Awesome (5,34) | 24.88 | Buy |
| Ultimate (7,14,28) | 79.62 | Sell |
| Momentum (10) | 25.74 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 331.74 | Sell |
| ADX (14) | 20.83 | Buy |
| ATR (14) | 4.55 | Info |
Trading at $314.46, Bio-Rad has a near-term price range within the last 30 days of $279.64 to $353.61. The stock shows a bullish technical stance, with RSI14 at 70 and moving averages of $291.22 for the SMA50 and $295.04 for the SMA200. A support level is seen at $270.32 and a resistance at $316.38.
The annualized volatility is 30% and the 30-day range indicates potential for movement within the stated band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $241.71 | $326.72 | $436.63 | 0% | Neutral | |
| $327.43 | $399.34 | $508.93 | +22% | Bullish | |
| $353.06 | $438.79 | $574.58 | +34% | Bullish | |
| $394.22 | $497.57 | $665.57 | +52% | Bullish | |
| $411.86 | $526.91 | $717.61 | +61% | Bullish | |
| $474.71 | $614.76 | $850.57 | +88% | Bullish | |
| $577.45 | $756.29 | $1,061.35 | +131% | Bullish | |
| $633.12 | $837.97 | $1,191.27 | +156% | Bullish | |
| $664.41 | $888.15 | $1,277.76 | +172% | Bullish | |
| $677.48 | $914.22 | $1,329.96 | +180% | Bullish | |
| $1,070.57 | $1,506.90 | $2,297.58 | +361% | Bullish | |
| $1,962.57 | $2,962.93 | $4,843.12 | +807% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $241.71 | $326.72 | $380.50 | +0.00% |
| August 2026 | $287.58 | $335.32 | $398.46 | +2.63% |
| September 2026 | $298.25 | $349.76 | $419.54 | +4.31% |
| October 2026 | $300.77 | $354.34 | $428.18 | +1.31% |
| November 2026 | $297.20 | $351.44 | $427.24 | -0.82% |
| December 2026 | $301.04 | $357.22 | $436.63 | +1.64% |
Click any year to see its month-by-month BIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BIO price prediction for 2026 points to an average of $326.72 (low $241.71, high $436.63) — a potential gain of 0% on today's $326.72. A consolidation phase looks the most probable path here.
In 2027, BIO is projected to trade between $327.43 and $508.93, averaging $399.34 — a potential gain of +22% from today's $326.72. That is up +22% on the projected 2026 average. Momentum favours further upside here.
Bio-Rad Laboratories, Inc.'s 2028 outlook centres on $438.79, within a $353.06 to $574.58 range. That is up +10% on the projected 2027 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BIO could reach as high as $665.57, with a base case around $497.57 and support toward $394.22 — roughly +52% from $326.72. Momentum favours further upside here.
Expect BIO to range from $411.86 to $717.61 through 2030. The $526.91 average target implies a +61% move from current prices. That is up +6% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The BIO price prediction for 2031 points to an average of $614.76 (low $474.71, high $850.57) — a potential gain of +88% on today's $326.72. Momentum favours further upside here.
In 2032, BIO is projected to trade between $577.45 and $1,061.35, averaging $756.29 — a potential gain of +131% from today's $326.72. That is up +23% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Bio-Rad Laboratories, Inc.'s 2033 outlook centres on $837.97, within a $633.12 to $1,191.27 range. That is up +11% on the projected 2032 average. That marks a +156% change versus current levels. Momentum favours further upside here.
By 2034, BIO could reach as high as $1,277.76, with a base case around $888.15 and support toward $664.41 — roughly +172% from $326.72. Buyers look set to stay in control over this stretch.
Expect BIO to range from $677.48 to $1,329.96 through 2035. The $914.22 average target implies a +180% move from current prices. That is up +3% on the projected 2034 average. Momentum favours further upside here.
The BIO price prediction for 2040 points to an average of $1,506.90 (low $1,070.57, high $2,297.58) — a potential gain of +361% on today's $326.72. Buyers look set to stay in control over this stretch.
In 2050, BIO is projected to trade between $1,962.57 and $4,843.12, averaging $2,962.93 — a potential gain of +807% from today's $326.72. That is up +97% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BIO today (≈ 3.060725 BIO) could be worth
$9,068.71
+$8,068.71 (+807%) by 2050 · US Dollar
Based on the average projected BIO price of $2,962.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIOwould be worth at today's price.
$1,000 invested in BIO on Jul 30, 2025 (≈ 3.99872 BIO) would be worth
$1,306.46
+$306.46 (+30.6%) today · 1.31× · US Dollar
Based on a BIO entry price of $250.08 vs. today's $326.72.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $316.38 | $1,032.68 | +3.3% |
| 1 month ago | $293.61 | $1,112.77 | +11.3% |
| 3 months ago | $256.55 | $1,273.51 | +27.4% |
| 6 months ago | $293.7 | $1,112.43 | +11.2% |
| 1 year ago | $250.08 | $1,306.46 | +30.6% |
| All time (5.0y) ago | $736.47 | $443.63 | -55.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIO forecast.
Our base-case forecast reaches $650.00 around 2032.
Implied market cap at $650.00: $14.11B
The multi-year forecast shows sustained upside with bullish sentiment across the horizon. For 2026, the average price is $314.46 with a min of $241.71 and a max of $421.73 (ROI 0). Looking ahead, 2030 projects an average of $502.00 with a min of $392.34 and a max of $683.81 (ROI 59.6, sentiment BULLISH).
The 2040 forecast shows an average of $1,425.33 (min $1,012.53, max $2,173.40) with a strong ROI of 353.3% (sentiment BULLISH). By 2050, the average price is projected at $2,796.14 (min $1,851.97, max $4,570.79) for an ROI of 789.2% (sentiment BULLISH). These are estimates and not guarantees, and they reflect bullish long-term potential alongside substantial volatility risks.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $502.00 with a min of $392.34 and a max of $683.81, with an estimated ROI of 59.6% and a bullish sentiment.
The forecast data indicate bullish sentiment from 2027 onward with rising averages toward 2030 ($502.00), 2040 ($1,425.33), and 2050 ($2,796.14), with ROIs up to 789.2%. These are estimates, not guarantees.
Yes. The 30-day range is $279.64 to $353.61 and the resistance is $316.38, suggesting potential movement toward and beyond $316 if momentum continues.
Current price is $314.46 and the market cap is $8.42B.
2030: average $502.00; 2040: average $1,425.33; 2050: average $2,796.14. All years show bullish sentiment with progressively higher average prices and ROIs (59.6% in 2030, 353.3% in 2040, 789.2% in 2050).
Bio-Rad Laboratories, Inc. Community Discussion
0Share your Bio-Rad Laboratories, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.